首页
浏览量: 191
- 产品名称： Anti SARS-CoV-2(2019-nCoV) South Africa spike variant Neutralizing antibody(B.1.351)
- 产品货号： CSMA10330Mo
- 货期： 现货
- 价格与订购： 2880
- 数量：
库存： 100
- 规格：
- 产品信息
- 如何订购
产品名称（Product name）
Anti SARS-CoV-2(2019-nCoV) South Africa spike variant Neutralizing antibody(B.1.351)
货号（Catalog#）
CSMA10330Moicon
描述（description）
Recombinant anti SARS-CoV-2(2019-nCoV) South Africa spike variant Neutralizing antibody(B.1.351) is expressed from XtenCHO
iconiconicon
别名（Alternative names)
Anti Spike glycoprotein antibody
稳定性&储存（Stability &Storage）
Use a manual defrost freezer and avoid repeated freeze thaw cycles.
Store at 2 to 8 °C for one week .
Store at -20 to -80 °C for twelve months from the date of receipt.
特异性（Spcificty）
Recognizes SARS-CoV-2(2019-nCoV) South Africa spike variant Protein
亚型（Isotype）
Human IgG
克隆性（Clonality）
Monoclonal
偶连物（Conjugation）
Unconjugate
种属反应性（Species reactivity）
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
应用实验（Tested applications）
WB,ELISAiconiconicon
免疫原（Immunogen）
Recombinant SARS-CoV-2(2019-nCoV) South Africa spike variant protein
背景（Background）
Cleavage by the viral main protease, 3CLpro results in generating the nsp8 protein, The nsp8 protein has been shown to associate with several other nsps and to colocalize with these nsps in cytoplasmic complexes that are important for viral RNA synthesis. It forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, may synthesize substantially longer products than oligonucleotide primers. Nsp8 was shown to have RNA-dependent RNA polymerase (RdRp) activity that could be involved in producing primers utilized by nsp12 which is normally accepted to be the RdRp for SARS-CoV.icon
状态（Form）
Liquidicon
储存溶液（Buffer）
PBS,pH7.5
iconicon
应用实验及稀释比例（Dilution Range）
WB:1:1000-2000; ELISA:1:5000-1:10000
iconicon
iconicon
Note
For research use only .
地 址：
产品销售：
E - mail ：
邮 编：
Amily
